A new drug has been invented which appears promising enough to block the HIV before getting into human cells. The medication is referred to as VIR-576, and research is still going on to assess effectiveness of the drugs on human body. The traditional approach of antiretroviral therapy, tries to stop cell growth after it has invaded the body.
The new drug for preventing HIV looks very promising, and if it is successful it would surely help reduce rising number of cases of HIV. HIV/AIDS is one of the deadly diseases that are caused due to many reasons, principal among them being the transfer of the virus from infected person to healthy person while having sex. This is one of the major sexually transmitted diseases (STD) that is causing much concern among health experts around the world, especially in gay communities. MSM (Men who have sex with men) are more susceptible to this disease due to lack of HIV test and treatment facilities for them.
The new drug should also have fewer side effects and would work effectively against virus. When virus replicate, they transform so as to become resistant to the drugs. But this would not happen, as the explored drug looks for removing the virus even before they are invaded. It targets different parts of the virus, called fusion peptide, unlike other virus. Two common drugs for HIV are T-20 and maraviroc which also block virus from entering the body but it do not target the fusion peptides.
This test revealed that fusion peptides are the best target to prevent HIV effectively in human body.